Some embodiments of the invention may be related to an apparatus for non-invasive directional tissue treatment. The apparatus includes a radiofrequency (RF) generator and an array of RF energy delivery elements in active communication with the RF generator, a power source and a controller. In some embodiments, each of the RF energy delivery elements comprises a pair of electrodes with opposite polarity such that each electrode has a first dimension and a second dimension, the first dimension perpendicular to the second dimension and to an imaginary line connecting the pair of electrodes to each other. In some embodiments, the first dimension of each electrode and the distance between the electrodes in each pair are configured to create an elongated heated volume of tissue when the RF generator is activated and at least one of the RF delivery elements is in contact with the tissue.

An example pump for driving a biological fluid is described herein. The pump can include an inner tubular structure and an outer tubular structure arranged around the inner tubular structure. The outer tubular structure can be configured as an artificial muscle. The pump can also include a gel layer disposed between the inner and outer tubular structures.

A multi-layered electronic device including two or more stacked metal conducting layers, a dielectric layer disposed between metal conducting layers, and at least one electrical connection extending between contact pads of metal conducting layers and through a through hole of the dielectric layer is provided. A system including at least one multi-layered electronic device, a satellite coupled to at least one multi-layered electronic device, and a controller hub electrically connected to the multi-layered electronic device via the satellite is also provided. A method of manufacturing the multi-layered electronic device including forming first and second first metal conducting layers, depositing a dielectric layer adjacent to the metal conducting layers, and connecting the metal conducting layers is also provided.

A device for electrostimulation or for data acquisition by diagnostic instruments has at least one electrode unit with the following layers: a) base layer with at least one electrode disposed in or on the base layer, and b) layer with one of the following layer structures: b1) plastic layer and layer of knitted fabric and plastic layer or b2) layer of knitted fabric and plastic layer or b3) plastic layer and layer of knitted fabric. The layers a) and b) are joined tightly with one another.

A method to provide skin care treatment is provided. The method includes receiving, by an electrical stimulator apparatus, programmable instructions from an external device for a skin care treatment. The electrical stimulator apparatus delivers an electric current to an area of skin through a plurality of electrodes. The electric current is controlled based on the skin care treatment. The external device presents guidance corresponding with the skin care treatment. The guidance is configured to aid a user in operating the electrical stimulator apparatus.

A transcranial direct current stimulation (tDCS) apparatus includes a stimulation unit, a control unit, and an input/output (I/O) unit. The stimulation unit includes a power-supply unit to supply power for electrical stimulation corresponding to a control signal received from the control unit, and a plurality of stimulation electrodes, each of which has a hydrogel patch, to provide electrical stimulation to a living body upon receiving the power from the power-supply unit. The control unit is configured to control an on/off function of the power-supply unit such that the power-supply unit is turned on or off according to the amount of power applied to the stimulation electrodes and a time period during which the power is supplied or not supplied.

A system for providing electrical stimulation to a patient includes a processor configured to: provide a time-ordered arrangement of multiple stimulation instances, where each of the stimulation instances is configured to produce a different stimulation field from each other stimulation instance in the arrangement; provide an ON/OFF switch pattern that includes alternating ON periods and OFF periods; generate an intermittent stimulation program that corresponds to repetition of the arrangement of stimulation instances with omission of each of the stimulation instances occurring during the OFF periods; and initiate a signal that provides a pulse generator with instructions that enable the pulse generator to generate stimulation according to the intermittent stimulation program using an electrical stimulation lead coupled to the pulse generator.

The invention comprises providing electric stimuli, which are generated by forming the following ringing circuit: active electrode—inductive storage unit—passive electrode—interelectrode tissues—active electrode, the electric stimuli creating oscillations which are used as a test signal. In one variant of the method, the electrodes are successively applied (in another variant—moved uniformly) across the skin area. Every time the electrodes-to-skin contact is detected, the oscillation parameters are recorded after a delay. Moreover, the values of parameters can be averaged. The invention allows for both combined and disjointed (i.e. separated) electrode placement. An optimal zone for electropulse therapy is identified by a minimal or maximal value of one or more parameters of the aforementioned oscillations and the use of the principle of small asymmetry. The invention further provides for an increase in the accuracy with which zones optimal for electropulse therapy are identified and localized.

A method and system is provided for administering a Repetitive Transcranial Magnetic Stimulation (rTMS) or Transcranial Alternating Current Stimulation (tACS) at a pulse interval of is set equal to the period of a curve that best fits a section of a person's electroencephalogram (EEG) recorded before the pulse train.

A disposable device designed to enhance the safety of capacitive radiofrequency therapies is described that is able to prevent risks arising from lesions present on the dielectric surface of the insulated electrode or on the stratum corneum of the skin, as well as risks arising from the use of technologies placed on the market before the certification of non-cytotoxicity of the parts applied to the patient (ISO 10993: 2018) was required, as well as the risks of contamination of parts applied in therapies previously performed on other patients.